GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2076 - 2100 of 4050 in total
Antibody ▼ Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 2 3 mild
G30839DN
628
IgG Patient 2 3 mild
G31265MS
1728
IgG Patient 2 3 mild
G32473MI
11348
IgG Patient 2 3 mild
G32611KT
29
IgG Patient 2 3 mild
G32699RJ
47
IgG Patient 2 3 mild
G35446HX
1491
IgG Patient 2 3 mild
G36191CD
80
IgG Patient 2 3 mild
G36374CE
255
IgG Patient 2 3 mild
G36544AC
258
IgG Patient 2 3 mild
G37036SF
6434
IgG Patient 2 3 mild
G37383BH
29
IgG Patient 2 3 mild
G38488WF
1622
IgG Patient 2 3 mild
G39023AU
45
IgG Patient 2 3 mild
G39213VZ
67
IgG Patient 2 3 mild
G40696TO
30
IgG Patient 2 3 mild
G41200QS
1878
IgG Patient 2 3 mild
G42346AP
51
IgG Patient 2 3 mild
G42666HT
3078
IgG Patient 2 3 mild
G43534QA
32
IgG Patient 2 3 mild
G43648DB
41
IgG Patient 2 3 mild
G47362BJ
3585
IgG Patient 2 3 mild
G47548GA
94
IgG Patient 2 3 mild
G47566FL
8386
IgG Patient 2 3 mild
G48898TH
831
IgG Patient 2 3 mild
G49108TO
453

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024